<p>(<b>A</b>) Sp1 activated the RLIM promoter activity. H1299 cells were cotransfected with 100 ng of NP500-Luc with either 160 ng pCMV empty vector as control or increasing amounts (0, 10, 20, 40, 80 and 160 ng) of pCMV-Myc-Sp1 plasmid. The total amount of plasmid in each transfection was adjusted to be the same using the empty vector. Cells were harvested 30 h after transfection and lysed for measuring luciferase activity. (<b>B</b>) p53 inhibits Sp1-stimulated activity of the RLIM luciferase reporter. H1299 cells were cotransfected with 100 ng of NP500-Luc and increasing amounts (0, 1, 2.5, 5 and 10 ng) of pCMV-HA-p53 plasmid in the presence of a fixed amount (160 ng) of pCMV-Myc-Sp1 plasmid. H1299 cells were transfected with 100 ng NP50...
<p>(<b>A</b>) p53 directly interacts with and sequesters Sp1 from the RLIM promoter, thereby inhibit...
RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Dea...
The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription fac...
<p>(<b>A</b>) Schematic representation of the RLIM promoter luciferase reporter construct NP500-Luc ...
<p>Transient co-transfections of the SALL2 P2 promoter-luciferase reporter constructs with or withou...
<p>(A) <i>p53</i><sup>−/−</sup> HCT116 cells were transfected with the <i>GFI1</i> promoter (−1933/+...
<p><b>Copyright information:</b></p><p>Taken from "Cancer-derived p53 mutants suppress p53-target ge...
<p>(A) H1299 cells were co-transfected by vectors coding for p53 proteins and a vector expressing th...
<p><b>A</b>) <i>p53<sup>−/−</sup></i> H1299 cells were co-transfected with a p53 expression plasmid ...
<p>(A) H1299 cells were transfected with pcDNA 3.0, wild-type p53, mutant p53 248W, or ΔTAp53 expres...
<p><b>A</b>) A putative p53 binding site is observed in the TRPC6 promoter using Genomatix, Matinspe...
<p>(<b>A</b>) U2-OS cells were treated with 20 µM etoposide for the indicated period (0, 6 and 12 h)...
<p>(A) Nucleotide sequences of wild type (WT) and mutated <i>GFI1</i> core promoter fragments as com...
We have studied the effects of human wild-type and mutant p53s on the long terminal repeat (LTR) pro...
<p>Cells were transfected with a plasmid containing either WT p53 or that containing the novel mutat...
<p>(<b>A</b>) p53 directly interacts with and sequesters Sp1 from the RLIM promoter, thereby inhibit...
RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Dea...
The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription fac...
<p>(<b>A</b>) Schematic representation of the RLIM promoter luciferase reporter construct NP500-Luc ...
<p>Transient co-transfections of the SALL2 P2 promoter-luciferase reporter constructs with or withou...
<p>(A) <i>p53</i><sup>−/−</sup> HCT116 cells were transfected with the <i>GFI1</i> promoter (−1933/+...
<p><b>Copyright information:</b></p><p>Taken from "Cancer-derived p53 mutants suppress p53-target ge...
<p>(A) H1299 cells were co-transfected by vectors coding for p53 proteins and a vector expressing th...
<p><b>A</b>) <i>p53<sup>−/−</sup></i> H1299 cells were co-transfected with a p53 expression plasmid ...
<p>(A) H1299 cells were transfected with pcDNA 3.0, wild-type p53, mutant p53 248W, or ΔTAp53 expres...
<p><b>A</b>) A putative p53 binding site is observed in the TRPC6 promoter using Genomatix, Matinspe...
<p>(<b>A</b>) U2-OS cells were treated with 20 µM etoposide for the indicated period (0, 6 and 12 h)...
<p>(A) Nucleotide sequences of wild type (WT) and mutated <i>GFI1</i> core promoter fragments as com...
We have studied the effects of human wild-type and mutant p53s on the long terminal repeat (LTR) pro...
<p>Cells were transfected with a plasmid containing either WT p53 or that containing the novel mutat...
<p>(<b>A</b>) p53 directly interacts with and sequesters Sp1 from the RLIM promoter, thereby inhibit...
RLIM acts as a negative regulator of LIM-Homeodomain proteins either by recruiting Sin3A/Histone Dea...
The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription fac...